Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Prevalence and correlates of depressive symptoms and resiliency among African American women in a community-based primary health care center.

Holden KB, Bradford LD, Hall SP, Belton AS.

J Health Care Poor Underserved. 2013 Nov;24(4 Suppl):79-93. doi: 10.1353/hpu.2014.0012.

2.

Characterizing depression and comorbid medical conditions in African American women in a primary care setting.

Shim RS, Baltrus P, Bradford LD, Holden KB, Fresh E, Fuller LE Sr.

J Natl Med Assoc. 2013 Summer;105(2):183-91.

3.

Psychosocial and sociocultural correlates of depressive symptoms among diverse African American women.

Holden KB, Hall SP, Robinson M, Triplett S, Babalola D, Plummer V, Treadwell H, Bradford LD.

J Natl Med Assoc. 2012 Nov-Dec;104(11-12):493-504.

4.

Persistent infection with neurotropic herpes viruses and cognitive impairment.

Watson AM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, Bradford LD, Calkins ME, Richard J, Edwards N, Savage RM, Allen TB, Kwentus J, McEvoy JP, Santos AB, Wiener HW, Go RC, Perry RT, Nasrallah HA, Gur RE, Devlin B, Nimgaonkar VL.

Psychol Med. 2013 May;43(5):1023-31. doi: 10.1017/S003329171200195X. Epub 2012 Sep 14.

PMID:
22975221
5.

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.

Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H, Klei L, Gur RC, Bradford LD, Calkins ME, Santos AB, Edwards N, Kwentus J, McEvoy JP, Allen TB, Savage RM, Nasrallah HA, Gur RE, Perry RT, Go RC, Devlin B, Yolken R, Nimgaonkar VL.

Schizophr Bull. 2012 Nov;38(6):1149-54. doi: 10.1093/schbul/sbs087. Epub 2012 Sep 10.

6.

Heritability of functioning in families with schizophrenia in relation to neurocognition.

Savage RM, Wiener HW, Nimgaonkar V, Devlin B, Calkins ME, Gur RE, O'Jile J, Bradford LD, Edwards N, Kwentus J, Allen T, McEvoy JP, Nasrallah H, Santos AB, Aduroja T, Lahti A, May RS, Montgomery-Barefield L, Go RC.

Schizophr Res. 2012 Aug;139(1-3):105-9. doi: 10.1016/j.schres.2012.04.015. Epub 2012 May 23.

PMID:
22627125
7.

Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects.

Wiener H, Klei L, Calkins M, Wood J, Nimgaonkar V, Gur R, Bradford LD, Richard J, Edwards N, Savage R, Kwentus J, Allen T, McEvoy J, Santos A, Gur R, Devlin B, Go R.

Schizophr Bull. 2013 Mar;39(2):464-71. doi: 10.1093/schbul/sbr161. Epub 2012 Jan 10.

8.

In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression.

Ramamoorthy A, Li L, Gaedigk A, Bradford LD, Benson EA, Flockhart DA, Skaar TC.

Drug Metab Dispos. 2012 Apr;40(4):726-33. doi: 10.1124/dmd.111.040329. Epub 2012 Jan 9.

9.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients.

Calkins ME, Tepper P, Gur RC, Ragland JD, Klei L, Wiener HW, Richard J, Savage RM, Allen TB, O'Jile J, Devlin B, Kwentus J, Aliyu MH, Bradford LD, Edwards N, Lyons PD, Nimgaonkar VL, Santos AB, Go RC, Gur RE.

Am J Psychiatry. 2010 Apr;167(4):459-72. doi: 10.1176/appi.ajp.2009.08091351. Epub 2010 Mar 1.

10.

Linkage analysis of schizophrenia in African-American families.

Wiener HW, Klei L, Irvin MD, Perry RT, Aliyu MH, Allen TB, Bradford LD, Calkins ME, Devlin B, Edwards N, Gur RE, Gur RC, Kwentus J, Lyons PD, McEvoy JP, Nasrallah HA, Nimgaonkar VL, O'Jile J, Santos AB, Savage RM, Go RC.

Schizophr Res. 2009 Apr;109(1-3):70-9. doi: 10.1016/j.schres.2009.02.007. Epub 2009 Mar 5.

11.

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples.

Talkowski ME, McClain L, Allen T, Bradford LD, Calkins M, Edwards N, Georgieva L, Go R, Gur R, Gur R, Kirov G, Chowdari K, Kwentus J, Lyons P, Mansour H, McEvoy J, O'Donovan MC, O'Jile J, Owen MJ, Santos A, Savage R, Toncheva D, Vockley G, Wood J, Devlin B, Nimgaonkar VL.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):560-9. doi: 10.1002/ajmg.b.30862.

12.

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.

Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, Leeder JS.

Clin Pharmacol Ther. 2008 Feb;83(2):234-42. Epub 2007 Oct 31.

PMID:
17971818
13.

Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.

Gaedigk A, Eklund JD, Pearce RE, Leeder JS, Alander SW, Phillips MS, Bradford LD, Kennedy MJ.

Clin Pharmacol Ther. 2007 Jun;81(6):817-20. Epub 2007 Mar 28.

PMID:
17392730
14.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods.

Aliyu MH, Calkins ME, Swanson CL Jr, Lyons PD, Savage RM, May R, Wiener H, McLeod-Bryant S, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, Kwentus J, McEvoy JP, Santos AB, McCleod-Bryant S, Tennison C, Go RC, Allen TB; PAARTNERS Study Group.

Schizophr Res. 2006 Oct;87(1-3):32-44. Epub 2006 Aug 2. Erratum in: Schizophr Res. 2007 Feb;90(1-3):369. Allen, Trina B [added]; Devlin, Bernie [corrected to McLeod-Bryant, Stephen].

PMID:
16887335
15.

CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.

Gaedigk A, Bradford LD, Alander SW, Leeder JS.

Drug Metab Dispos. 2006 Apr;34(4):563-9. Epub 2006 Jan 13.

PMID:
16415111
16.

Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans.

Gaedigk A, Bhathena A, Ndjountché L, Pearce RE, Abdel-Rahman SM, Alander SW, Bradford LD, Rogan PK, Leeder JS.

Pharmacogenomics J. 2005;5(3):173-82. Erratum in: Pharmacogenomics J. 2005;5(4):276. Rogan, PK [added].

17.

Limited association of the 2988g > a single nucleotide polymorphism with CYP2D641 in black subjects.

Gaedigk A, Ndjountché L, Leeder JS, Bradford LD.

Clin Pharmacol Ther. 2005 Mar;77(3):228-30; author reply 230-1. No abstract available.

PMID:
15735618
18.

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects.

Gaedigk A, Ndjountché L, Gaedigk R, Leeder JS, Bradford LD.

Clin Pharmacol Ther. 2003 Jun;73(6):575-6. No abstract available.

PMID:
12811367
19.

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism.

Gaedigk A, Ryder DL, Bradford LD, Leeder JS.

Clin Chem. 2003 Jun;49(6 Pt 1):1008-11. No abstract available.

20.

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.

Gaedigk A, Bradford LD, Marcucci KA, Leeder JS.

Clin Pharmacol Ther. 2002 Jul;72(1):76-89.

PMID:
12152006
21.

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.

Bradford LD.

Pharmacogenomics. 2002 Mar;3(2):229-43. Review.

PMID:
11972444
22.

Polymorphism of CYP2D6 in Black populations: implications for psychopharmacology.

Bradford LD, Kirlin WG.

Int J Neuropsychopharmacol. 1998 Dec;1(2):173-185.

PMID:
11281961
23.

High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data.

Bradford LD, Gaedigk A, Leeder JS.

Psychopharmacol Bull. 1998;34(4):797-804. Review.

PMID:
10513455
25.

Biochemical effects in rats after acute and long-term treatment with clovoxamine.

Bradford LD, Tulp MT, Schipper J.

Arch Int Pharmacodyn Ther. 1987 Jun;287(2):188-202.

PMID:
2820327
26.

Serenics: the pharmacology of fluprazine and DU 28412.

Bradford LD, Olivier B, van Dalen D, Schipper J.

Prog Clin Biol Res. 1984;167:191-207. No abstract available.

PMID:
6150489
27.

A tethering system for intravenous and intragastric drug administration in the baboon.

Lukas SE, Griffiths RR, Bradford LD, Brady JV, Daley L.

Pharmacol Biochem Behav. 1982 Oct;17(4):823-9.

PMID:
7178190
28.

Comparison of barbiturate and benzodiazepine self-injection in the baboon.

Griffiths RR, Bradford LD, Lukas SE, Brady JV, Snell JD.

NIDA Res Monogr. 1982 Apr;41:190. No abstract available.

PMID:
6811908
29.

Self-injection of barbiturates and benzodiazepines in baboons.

Griffiths RR, Lukas SE, Bradford LD, Brady JV, Snell JD.

Psychopharmacology (Berl). 1981;75(2):101-9.

PMID:
6119723
30.

Responding maintained by cocaine or d-amphetamine under fixed-interval schedules in baboons.

Bradford LD, Griffiths RR.

Drug Alcohol Depend. 1980 May;5(5):393-400. No abstract available.

PMID:
6768538
31.

Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons.

Griffiths RR, Bradford LD, Brady JV.

Psychopharmacology (Berl). 1979 Oct;65(2):125-36.

PMID:
117480
32.

Behavioral assessment of risk-taking and psychophysical functions in the baboon.

Brady JV, Bradford LD, Hienz RD.

Neurobehav Toxicol. 1979;1 Suppl 1:73-84.

PMID:
299585

Supplemental Content

Loading ...
Support Center